X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE SANOFI INDIA TTK HEALTHCARE/
SANOFI INDIA
 
P/E (TTM) x 26.3 34.3 76.7% View Chart
P/BV x 5.8 6.9 84.4% View Chart
Dividend Yield % 0.5 1.3 38.2%  

Financials

 TTK HEALTHCARE   SANOFI INDIA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
SANOFI INDIA
Dec-16
TTK HEALTHCARE/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs6634,560 14.5%   
Low Rs3994,400 9.1%   
Sales per share (Unadj.) Rs535.61,028.5 52.1%  
Earnings per share (Unadj.) Rs15.9129.0 12.4%  
Cash flow per share (Unadj.) Rs20.0186.0 10.8%  
Dividends per share (Unadj.) Rs4.0068.00 5.9%  
Dividend yield (eoy) %0.81.5 49.6%  
Book value per share (Unadj.) Rs137.6753.6 18.3%  
Shares outstanding (eoy) m7.7723.03 33.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.4 22.8%   
Avg P/E ratio x33.334.7 95.9%  
P/CF ratio (eoy) x26.524.1 110.1%  
Price / Book Value ratio x3.95.9 64.9%  
Dividend payout %25.152.7 47.6%   
Avg Mkt Cap Rs m4,127103,174 4.0%   
No. of employees `0001.73.6 47.1%   
Total wages/salary Rs m6073,592 16.9%   
Avg. sales/employee Rs Th2,436.76,537.7 37.3%   
Avg. wages/employee Rs Th355.2991.4 35.8%   
Avg. net profit/employee Rs Th72.5819.8 8.8%   
INCOME DATA
Net Sales Rs m4,16223,686 17.6%  
Other income Rs m61708 8.6%   
Total revenues Rs m4,22324,394 17.3%   
Gross profit Rs m1975,281 3.7%  
Depreciation Rs m321,313 2.4%   
Interest Rs m3015 199.3%   
Profit before tax Rs m1974,661 4.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m731,691 4.3%   
Profit after tax Rs m1242,970 4.2%  
Gross profit margin %4.722.3 21.2%  
Effective tax rate %37.036.3 102.0%   
Net profit margin %3.012.5 23.7%  
BALANCE SHEET DATA
Current assets Rs m1,62915,673 10.4%   
Current liabilities Rs m1,0586,678 15.8%   
Net working cap to sales %13.738.0 36.1%  
Current ratio x1.52.3 65.6%  
Inventory Days Days3076 39.2%  
Debtors Days Days3422 150.5%  
Net fixed assets Rs m5568,098 6.9%   
Share capital Rs m78230 33.7%   
"Free" reserves Rs m87817,088 5.1%   
Net worth Rs m1,06917,356 6.2%   
Long term debt Rs m1590-   
Total assets Rs m2,39925,400 9.4%  
Interest coverage x7.6311.7 2.4%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.70.9 186.0%   
Return on assets %6.411.8 54.5%  
Return on equity %11.617.1 67.7%  
Return on capital %18.526.9 68.5%  
Exports to sales %0.824.5 3.2%   
Imports to sales %1.428.0 5.0%   
Exports (fob) Rs m335,801 0.6%   
Imports (cif) Rs m586,627 0.9%   
Fx inflow Rs m337,145 0.5%   
Fx outflow Rs m636,846 0.9%   
Net fx Rs m-30299 -10.1%   
CASH FLOW
From Operations Rs m1273,226 3.9%  
From Investments Rs m-146-1,555 9.4%  
From Financial Activity Rs m22-1,818 -1.2%  
Net Cashflow Rs m3-147 -1.7%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 3.7 14.4 25.7%  
FIIs % 5.2 14.6 35.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 10.5 245.7%  
Shareholders   12,723 15,184 83.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   AUROBINDO PHARMA  MERCK LTD  GSK PHARMA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jun 22, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - ALEMBIC LTD COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS